Despite not altering tumorigenesis, PRL-3 WT and the phosphatase-dead C104D mutant increased tumor size, quantified as percent tumor burden (tumor size/body size), with both averaging ≥15.98% compared to 7.59% in the mCherry controls (p≤0.025). This evidence concerns the gene PTP4A3 and neoplasm.